TESTA, IVANO
 Distribuzione geografica
Continente #
NA - Nord America 671
EU - Europa 360
AS - Asia 161
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.194
Nazione #
US - Stati Uniti d'America 670
IE - Irlanda 145
CN - Cina 80
TR - Turchia 58
DE - Germania 41
SE - Svezia 41
GB - Regno Unito 37
UA - Ucraina 34
SG - Singapore 20
FI - Finlandia 17
FR - Francia 15
IT - Italia 13
BE - Belgio 10
IN - India 3
RU - Federazione Russa 3
AT - Austria 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
MX - Messico 1
NZ - Nuova Zelanda 1
Totale 1.194
Città #
Chandler 156
Dublin 145
Jacksonville 139
Ann Arbor 57
Boardman 50
New York 36
Izmir 30
San Mateo 30
Wilmington 30
Nanjing 24
Lawrence 18
Princeton 18
Singapore 16
Nanchang 11
Brussels 10
Woodbridge 10
Shenyang 8
Seattle 7
Verona 6
Des Moines 5
Düsseldorf 5
Falls Church 5
Los Angeles 5
Milan 5
Philadelphia 5
Zhengzhou 5
Kunming 4
Tianjin 4
Hebei 3
Jinan 3
Ashburn 2
Auburn Hills 2
Beijing 2
Changsha 2
Jiaxing 2
Ningbo 2
Santa Clara 2
Shanghai 2
Washington 2
Brno 1
Chicago 1
Dallas 1
Fuzhou 1
Guangzhou 1
Hangzhou 1
Houston 1
Lanzhou 1
London 1
Lower Hutt 1
Madrid 1
Mexico City 1
Phoenix 1
Rome 1
Taizhou 1
Tallinn 1
Vienna 1
Totale 885
Nome #
Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients 89
Fibronectin and lipoprotein(a) are inversely related to plasminogen activator inhibitor type-1 levels in NID diabetic patients without complications 85
Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. 85
Decreased insulin receptor but normal glucose metabolism in Duchenne muscolar dystrophy 84
In the Light of the Metabolic Memory Theory, Should Not All Aged People with Dysglycemia Be Treated? 77
Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects. 72
Glycosylated hemoglobin and fructosamines: does their determination really reflect the glycemic control in diabetic patients? 71
The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing 68
A significant relationship between plasminogen activator inhibitor type-1 and lipoprotein(a) in non-insulin-dependent diabetes mellitus without complications 64
Asymptomatic Helicobacter pylori Infection Increases Asymmetric Dimethylarginine Levels in Healthy Subjects 63
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment 62
Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients 59
Tissue-specific antibobies against the fibroblast insulin receptor in a patient with lupus nephritis and hypoglycemia 59
Metformin treatment in elderly type II diabetic patients 56
Erytrocyte insulin receptors in non insulin dependent diabetes mellitus 55
Age-dependent changes of serum oxygen radical scavenger capacity and haemoglobin glycosylation in non-insulin-dependent diabetic patients 51
One- and two-compartment minimal models detect similar alterations of glucose metabolism indexes in hypertension 51
Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study 45
Totale 1.196
Categoria #
all - tutte 4.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202093 0 0 0 3 1 18 29 1 19 3 1 18
2020/2021156 5 18 1 20 17 5 23 0 19 9 35 4
2021/2022114 9 15 16 9 9 2 5 9 6 5 7 22
2022/2023420 25 35 5 61 36 46 0 20 177 2 9 4
2023/202485 10 6 2 14 6 38 0 1 0 4 2 2
2024/202542 11 6 24 1 0 0 0 0 0 0 0 0
Totale 1.196